COMP <GO>
AVIR vs CTNM // REVENUE GROWTH (YOY)
Atea Pharmaceuticals Inc. (NASDAQ) VS. Contineum Therapeutics Inc. (Class A) (NASDAQ) • 15-METRIC TALLY: AVIR 1
— CTNM 3
■ METRIC PARITY
LAST: $4.31 (+0.94%) • MKT CAP: $345.7M
revenue-growth
—
LAST: $9.33 (+1.97%) • MKT CAP: $351.0M
revenue-growth
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AVIR VS. CTNM)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | AVIR | CTNM | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -29.00% | -6.00 | CTNM | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | -15.82% | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 2/9 | +1.00 | AVIR | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 32.4 | 43.0 | -10.65 | CTNM | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $345.7M | $351.0M | -$5.3M | CTNM | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | AVIR REV | CTNM REV | AVIR GROSS % | CTNM GROSS % | AVIR FCF | CTNM FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $0 | — | — | -$132.0M | -$55.5M |
| FY 2024 | $0 | $0 | — | — | -$135.5M | -$33.4M |
| FY 2023 | $0 | $50.0M | — | — | -$85.4M | $19.3M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AVIR // BETA —
CTNM // BETA —